Princeton, NJ (PRWEB) September 30, 2013
NovoPath announces support for the Citrix XenApp Platform to enable anywhere, anytime information access for its NovoPath anatomic pathology (AP) laboratory information system (LIS). This is in addition to NovoPath’s long standing support of the Microsoft Terminal Services Platform. Utilizing these technologies, laboratory professionals can securely manage cases outside of the laboratory with the same efficiency as if they were on-site while enabling the IT department to achieve seamless virtualization of the IT infrastructure.
"These platforms provide customers with even more flexibility by enabling seamless offsite access to NovoPath," says Rick Callahan, Vice President of Sales and Marketing for NovoPath. "We believe it is important to provide our clients with a choice in architecture to support remote employees to enable a flexible working environment. With a diversity of offerings, IT departments can save time and money and select the most appropriate NovoPath offering, given their existing IT infrastructure."
Callahan notes that these are time-tested, reliable and widely used methodologies that could extend the laboratory and its workstations beyond their physical boundaries. "Secure on-demand access to lab data in any setting speeds healthcare delivery, enables physicians to collaborate on difficult cases and empowers labs to succeed on a business level," adds Callahan. "Labs have a mandate to compete in a challenging environment where change is a way of life. Every clinical or business edge helps, and this is one more way NovoPath is committed to supporting the success of its customers."
In addition to Citrix and Terminal Services support, NovoPath’s NovoOutreach module provides the referring physician with web-based offsite order entry and results viewing. On the leading edge of technology, the system also can communicate results directly to referrers’ electronic medical record (EMR) and practice management systems, as well as a full range of mobile devices including most popular smartphones and tablets.
NovoPath, Inc. develops and markets software solutions for the Anatomic Pathology Laboratory market segment that includes local, regional, national, and in-house laboratories as well as community and university teaching hospitals and medical centers. Since the release of its flagship product in 1999, NovoPath, Inc. has focused exclusively on Anatomic Pathology. NovoPath's mission is to provide unique and unparalleled solutions and services to all aspects of the Anatomic Pathology sector in a way that improves workflow, reduces the probability of human error, ensures results accuracy for greater patient safety, protects patient confidentiality, and above all, produces more precise and informative diagnostic outcomes. More information is available at http://www.NovoPath.com.